ImageneBio, Inc.
IMA
$5.51
-$0.04-0.72%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 122.07% | 119.47% | 568.44% | -10.69% | 12.54% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.76% | 38.46% | 380.38% | 15.25% | -69.72% |
| Operating Income | -101.48% | -38.46% | -1,206.19% | -15.25% | 73.28% |
| Income Before Tax | -74.58% | -49.70% | -680.80% | -21.19% | 72.77% |
| Income Tax Expenses | -- | -2,223.08% | -- | -- | -- |
| Earnings from Continuing Operations | -74.74% | -43.56% | -678.48% | -21.19% | 72.77% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -74.74% | -43.56% | -678.48% | -21.19% | 72.77% |
| EBIT | -101.48% | -38.46% | -1,206.19% | -15.25% | 73.28% |
| EBITDA | -99.89% | -32.45% | -1,255.35% | -23.94% | 72.56% |
| EPS Basic | 75.05% | -3,534.12% | -2,826.82% | -9,611.24% | -4,747.64% |
| Normalized Basic EPS | 62.53% | -6,078.46% | -- | -- | -3,539.17% |
| EPS Diluted | 75.05% | -3,534.12% | -2,826.82% | -9,611.24% | -4,747.64% |
| Normalized Diluted EPS | 62.53% | -6,078.46% | -- | -- | -3,539.17% |
| Average Basic Shares Outstanding | 366.21% | -97.58% | -- | -- | -99.25% |
| Average Diluted Shares Outstanding | 366.21% | -97.58% | -96.52% | -99.56% | -99.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |